Thermo Fisher (TMO) announced the UK Biobank Pharma Proteomics Project, or UKB-PPP, has selected its Olink Explore Platform to support the ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
We recently published a list of the 12 Best Nanotechnology Stocks to Buy According to Hedge Funds. In this article, we are ...
Johnny Fisher battles Dave Allen in an all-British clash on the undercard for Tyson Fury's rematch against Oleksandr Usyk this evening. The former sparring partners will hope to prove their ...
Knipper Health and Thermo Fisher are partnering closely to ensure a seamless transition for all involved. “As the leading supplier of marketing and sample management solutions to the life sciences ...
Twelve years on from his professional debut in December 2012, the 32-year-old heavyweight is taking on one of his toughest challenges yet in highly-rated British prospect Johnny Fisher.
Thermo Fisher's stock is now a "buy" due to signs of recovery, including positive sales growth and stabilized margins, despite recent bearish trends. The company's post-pandemic challenges are ...
Professor Fisher received his undergraduate degree (in American Studies) from Amherst College and his graduate degrees (J.D. and Ph.D. in the History of American Civilization) from Harvard University.
Controller at Thermo Fisher Scientific, Finance Manager at Epix Pharmaceuticals and Senior Auditor at Arthur Andersen. Jon received his BS in Accounting at Providence College and is a licensed CPA.
The market is highly competitive, with major players like Agilent Technologies, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific holding significant market shares.